TipRanks
Oncopeptides AB (DE:OND)
FRANKFURT:OND
Germany Market
OND
Oncopeptides AB
RESEARCH TOOLSreports

Oncopeptides AB (OND) Stock News & Sentiment

6 Followers
Oncopeptides Raises SEK 100 Million in Discounted Directed Share Issue to Fund Glioblastoma Push
Premium
Company Announcements
Oncopeptides Raises SEK 100 Million in Discounted Directed Share Issue to Fund Glioblastoma Push
4h ago
Oncopeptides Seeks SEK 100m in Directed Share Issue to Accelerate Glioblastoma Program
Premium
Company Announcements
Oncopeptides Seeks SEK 100m in Directed Share Issue to Accelerate Glioblastoma Program
8h ago
Oncopeptides to Brief Investors After Positive Glioblastoma Study Data
Premium
Company Announcements
Oncopeptides to Brief Investors After Positive Glioblastoma Study Data
5d ago
Oncopeptides Reports Breakthrough Blood-Brain Barrier Data in Glioblastoma Study
Premium
Company Announcements
Oncopeptides Reports Breakthrough Blood-Brain Barrier Data in Glioblastoma Study
5d ago
Oncopeptides earns EANO poster nod as PDC platform pushes into glioblastoma
Premium
Company Announcements
Oncopeptides earns EANO poster nod as PDC platform pushes into glioblastoma
22d ago
Oncopeptides to Present New Pepaxti Data at Key Myeloma Meeting
Premium
Company Announcements
Oncopeptides to Present New Pepaxti Data at Key Myeloma Meeting
22d ago
Oncopeptides Wins EMA Backing to Move Pepaxti Into Third-Line Myeloma Use
Premium
Company Announcements
Oncopeptides Wins EMA Backing to Move Pepaxti Into Third-Line Myeloma Use
26d ago
More DE:OND News >

OND News on the Web

Oncopeptides to Brief Investors After Positive Glioblastoma Study Data
TipRanks News
Bullish
Oncopeptides Reports Breakthrough Blood-Brain Barrier Data in Glioblastoma Study
TipRanks News
Bullish
Oncopeptides AB Earnings Call Highlights Growth Momentum
TipRanks News
Bullish
Oncopeptides to Present Q2 2026 Results as Oncology Commercialization Expands
TipRanks News
Bullish
Oncopeptides launches German real-world study to bolster Pepaxti’s myeloma profile
TipRanks News
Bullish
Oncopeptides to spotlight Pepaxti data and PDC strategy at EHA 2026
TipRanks News
Bullish
Oncopeptides Accelerates CEE Expansion for Pepaxti via Exclusive Salus Distribution Deal
TipRanks News
Bullish
Oncopeptides AGM Backs Incentive Schemes and Expands Capital-Raising Mandate
TipRanks News
Neutral

News Score - Last 7 Days

Positive
DE:OND
Sector Average
Media Buzz
This Week2 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average89%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:OND’s Media Buzz Sentiment?
2 articles about DE:OND were published this week. In an average week, 0.75 articles are published.
    What is DE:OND’s weekly average amount of articles?
    In an average week, 0.75 articles about DE:OND are published.
      What is DE:OND’s News Sentiment?
      100% of articles about DE:OND were positive this week, compared to its sector average of 89%.
        General Stocks that are Trending in the News
        RPDRapid7
        TERATera Yatirim Menkul Degerler AS
        R2PD34Rapid7 Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.083333 Sh
        T2TD34Trade Desk, Inc. Shs A Unsponsored Brazilian Depositary Receipt Repr 0.01 Sh A
        T1AM34Atlassian Corp Shs A Unsponsored Brazilian Depository Receipt Repr 0.05 Sh A
        Showing the stocks with the most bullish news sentiment over the past week